GluN2A-ERK-mTOR pathway confers a vulnerability to LPS-induced depressive-like behaviour

Ester Francija1, Iva Lukic1, Zorica Petrovic2

  • 1Department of Molecular Biology and Endocrinology, "VINČA" Institute of Nuclear Sciences - National Institute of thе Republic of Serbia, University of Belgrade, Belgrade.

Insights

Mice lacking the GluN2A subunit of N-methyl-D-aspartate receptors (NMDAR) resist depression-like behaviors induced by inflammation. This resilience is linked to sustained mTOR signaling, highlighting GluN2A-ERK-mTOR pathways as potential antidepressant targets.

Area of Science:

  • Neuroscience
  • Molecular Psychiatry
  • Immunology

Background:

  • Inflammation and neuroinflammation are implicated in major depressive disorder (MDD) pathogenesis.
  • Neuroinflammation disrupts N-methyl-D-aspartate receptor (NMDAR)-mediated neurotransmission, contributing to depressive behaviors.
  • Mammalian target of rapamycin (mTOR) signaling, with its synaptogenic effects, mediates antidepressant actions of NMDAR antagonists.

Purpose of the Study:

  • To investigate the role of GluN2A subunits of NMDAR in modulating mTOR signaling and behavior within a lipopolysaccharide (LPS)-induced mouse model of depression.
  • To elucidate the specific contribution of GluN2A to inflammation-induced depressive-like behaviors and associated molecular changes.

Main Methods:

  • Utilized a lipopolysaccharide (LPS)-induced mouse model to mimic inflammation-related depression.
  • Compared depressive-like behaviors and molecular signaling in wild-type (WT) mice and GluN2A knockout (KO) mice.
  • Assessed mTOR pathway activity in the hippocampus and prefrontal cortex (PFC) by measuring levels of key signaling proteins (p-Akt, p-ERK, p-GSK3β, p-mTOR, p-p70S6K).
  • Quantified synaptic markers, including GluA1 and PSD-95, to evaluate synaptic integrity.

Main Results:

  • LPS administration induced depressive-like behaviors in WT mice but not in GluN2A KO mice.
  • LPS-treated WT mice exhibited downregulated mTOR signaling and reduced synaptic markers (GluA1, PSD-95) in the hippocampus and PFC.
  • GluN2A KO mice showed sustained mTOR signaling activity and synaptic stability, correlating with their resilience to depressive behaviors.
  • The resistance of GluN2A KO mice to LPS-induced depression was found to be dependent on ERK signaling.

Conclusions:

  • The GluN2A subunit of NMDAR is a critical factor in the vulnerability to inflammation-related depressive behaviors.
  • The GluN2A-ERK-mTOR signaling pathway plays a significant role in the pathogenesis of depression induced by immune challenges.
  • Targeting the GluN2A-ERK-mTOR pathway offers a promising strategy for the development of novel antidepressant therapies for inflammation-associated depression.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.5K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.0K